Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.8B | 8.4B | 7.8B | 7.9B |
| Cost of revenue | 4.1B | 4.4B | 4.2B | 4.3B |
| Gross profit | 3.7B | 3.9B | 3.7B | 3.6B |
| Operating expense | ||||
| Research & development | 731M | 773M | 746M | 718M |
| Selling general and admin | 991M | 1.2B | 1.0B | 1.0B |
| Other operating expenses | 398M | 451M | 427M | 436M |
| Operating income | 1.6B | 1.5B | 1.5B | 1.4B |
| Non operating interest income | ||||
| Income | 145M | 148M | 183M | 165M |
| Expense | 103M | 97M | 106M | 93M |
| Other income expense | -35M | -132M | -220M | -111M |
| Pretax income | 1.6B | 1.4B | 1.3B | 1.4B |
| Tax provision | 316M | 289M | 301M | 271M |
| Net income | 1.3B | 1.1B | 1.0B | 1.1B |
| Basic EPS | 1.3 | 1.1 | 1 | 1.1 |
| Diluted EPS | 1.3 | 1.1 | 1.0 | 1.1 |
| Basic average shares | 50.7M | 51.3M | 52.2M | 53.6M |
| Diluted average shares | 51.4M | 52.2M | 52.7M | 53.9M |
| EBITDA | 2.0B | 1.9B | 1.9B | 1.9B |
| Net income from continuing op. | 1.3B | 1.1B | 1.0B | 1.1B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |